Skip to search formSkip to main contentSkip to account menu

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
National Institutes of Health

Related topics

Related topics

3 relations
CHGA gene

Broader (2)

Chromogranin APeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury–Induced Neointimal Hyperplasia
Abstract Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have… 
2012
2012
Chromogranin A-derived peptides are involved in innate immunity.
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune… 
Review
2012
Review
2012
Cardioprotection against ischemia/reperfusion injury and chromogranin A-derived peptides.
Chromogranin A (CgA) is produced by cells of the sympathoadrenal system and by human ventricular myocardium. In the clinical… 
2011
2011
The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+-calcineurin-NFAT signaling pathway.
2011
2011
Catestatin is useful in detecting patients with stage B heart failure
Screening patients with stage B heart failure(HF) may be one strategy for reducing human morbidity. To describe catestatin levels… 
2010
2010
Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea.
BACKGROUND Obstructive sleep apnea (OSA) is common in children and leads to multiple end-organ morbidities induced by the… 
Highly Cited
2009
Highly Cited
2009
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… 
Highly Cited
2002
Highly Cited
2002
Modulatory Mechanism of the Endogenous Peptide Catestatin on Neuronal Nicotinic Acetylcholine Receptors and Exocytosis
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited… 
2000
2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A352-372) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic…
1998
1998
A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)